BEERSE, Belgium, January 18, 2018 /PRNewswire/ —
The Janssen Pharmaceutical Companies of Johnson & Johnson announce results of new real world evidence from a study of almost 30,000 people, which supports the benefits of long-acting antipsychotics (LATs) in reducing the risk of…
